Eye Disorders Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: E1ABB5FC2127EN
Market Monitor Global

Abstracts

Most treatment of eye diseases is aimed at reducing inflammation, repairing traumatic injuries and improving or saving eyesight.

This report contains market size and forecasts of Eye Disorders Treatments in Global, including the following market information:

Global Eye Disorders Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Eye Disorders Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cataract Surgery Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Eye Disorders Treatments include Johnson & Johnson, Novartis, Alimera Sciences, Teva Pharmaceutical, Eyetech Pharmaceuticals, Refocus Group and VisionCare Ophthalmic Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eye Disorders Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eye Disorders Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Eye Disorders Treatments Market Segment Percentages, by Type, 2021 (%)

• Cataract Surgery Devices
• Glaucoma Surgery Devices
• Vitreoretinal Surgery Devices
• Refractive Surgery Devices

Global Eye Disorders Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Eye Disorders Treatments Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Eye Disorders Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Eye Disorders Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Eye Disorders Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Eye Disorders Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Novartis
• Alimera Sciences
• Teva Pharmaceutical
• Eyetech Pharmaceuticals
• Refocus Group
• VisionCare Ophthalmic Technologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Eye Disorders Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Eye Disorders Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EYE DISORDERS TREATMENTS OVERALL MARKET SIZE

2.1 Global Eye Disorders Treatments Market Size: 2021 VS 2028
2.2 Global Eye Disorders Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Eye Disorders Treatments Players in Global Market
3.2 Top Global Eye Disorders Treatments Companies Ranked by Revenue
3.3 Global Eye Disorders Treatments Revenue by Companies
3.4 Top 3 and Top 5 Eye Disorders Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Eye Disorders Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Eye Disorders Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Eye Disorders Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Eye Disorders Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Eye Disorders Treatments Market Size Markets, 2021 & 2028
  4.1.2 Cataract Surgery Devices
  4.1.3 Glaucoma Surgery Devices
  4.1.4 Vitreoretinal Surgery Devices
  4.1.5 Refractive Surgery Devices
4.2 By Type - Global Eye Disorders Treatments Revenue & Forecasts
  4.2.1 By Type - Global Eye Disorders Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Eye Disorders Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Eye Disorders Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Eye Disorders Treatments Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Eye Disorders Treatments Revenue & Forecasts
  5.2.1 By Application - Global Eye Disorders Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Eye Disorders Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Eye Disorders Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Eye Disorders Treatments Market Size, 2021 & 2028
6.2 By Region - Global Eye Disorders Treatments Revenue & Forecasts
  6.2.1 By Region - Global Eye Disorders Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Eye Disorders Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Eye Disorders Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Eye Disorders Treatments Revenue, 2017-2028
  6.3.2 US Eye Disorders Treatments Market Size, 2017-2028
  6.3.3 Canada Eye Disorders Treatments Market Size, 2017-2028
  6.3.4 Mexico Eye Disorders Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Eye Disorders Treatments Revenue, 2017-2028
  6.4.2 Germany Eye Disorders Treatments Market Size, 2017-2028
  6.4.3 France Eye Disorders Treatments Market Size, 2017-2028
  6.4.4 U.K. Eye Disorders Treatments Market Size, 2017-2028
  6.4.5 Italy Eye Disorders Treatments Market Size, 2017-2028
  6.4.6 Russia Eye Disorders Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Eye Disorders Treatments Market Size, 2017-2028
  6.4.8 Benelux Eye Disorders Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Eye Disorders Treatments Revenue, 2017-2028
  6.5.2 China Eye Disorders Treatments Market Size, 2017-2028
  6.5.3 Japan Eye Disorders Treatments Market Size, 2017-2028
  6.5.4 South Korea Eye Disorders Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Eye Disorders Treatments Market Size, 2017-2028
  6.5.6 India Eye Disorders Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Eye Disorders Treatments Revenue, 2017-2028
  6.6.2 Brazil Eye Disorders Treatments Market Size, 2017-2028
  6.6.3 Argentina Eye Disorders Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Eye Disorders Treatments Revenue, 2017-2028
  6.7.2 Turkey Eye Disorders Treatments Market Size, 2017-2028
  6.7.3 Israel Eye Disorders Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Eye Disorders Treatments Market Size, 2017-2028
  6.7.5 UAE Eye Disorders Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Eye Disorders Treatments Major Product Offerings
  7.1.4 Johnson & Johnson Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Eye Disorders Treatments Major Product Offerings
  7.2.4 Novartis Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Alimera Sciences
  7.3.1 Alimera Sciences Corporate Summary
  7.3.2 Alimera Sciences Business Overview
  7.3.3 Alimera Sciences Eye Disorders Treatments Major Product Offerings
  7.3.4 Alimera Sciences Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.3.5 Alimera Sciences Key News
7.4 Teva Pharmaceutical
  7.4.1 Teva Pharmaceutical Corporate Summary
  7.4.2 Teva Pharmaceutical Business Overview
  7.4.3 Teva Pharmaceutical Eye Disorders Treatments Major Product Offerings
  7.4.4 Teva Pharmaceutical Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.4.5 Teva Pharmaceutical Key News
7.5 Eyetech Pharmaceuticals
  7.5.1 Eyetech Pharmaceuticals Corporate Summary
  7.5.2 Eyetech Pharmaceuticals Business Overview
  7.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Major Product Offerings
  7.5.4 Eyetech Pharmaceuticals Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.5.5 Eyetech Pharmaceuticals Key News
7.6 Refocus Group
  7.6.1 Refocus Group Corporate Summary
  7.6.2 Refocus Group Business Overview
  7.6.3 Refocus Group Eye Disorders Treatments Major Product Offerings
  7.6.4 Refocus Group Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.6.5 Refocus Group Key News
7.7 VisionCare Ophthalmic Technologies
  7.7.1 VisionCare Ophthalmic Technologies Corporate Summary
  7.7.2 VisionCare Ophthalmic Technologies Business Overview
  7.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Major Product Offerings
  7.7.4 VisionCare Ophthalmic Technologies Eye Disorders Treatments Revenue in Global Market (2017-2022)
  7.7.5 VisionCare Ophthalmic Technologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Eye Disorders Treatments Market Opportunities & Trends in Global Market
Table 2. Eye Disorders Treatments Market Drivers in Global Market
Table 3. Eye Disorders Treatments Market Restraints in Global Market
Table 4. Key Players of Eye Disorders Treatments in Global Market
Table 5. Top Eye Disorders Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Eye Disorders Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Eye Disorders Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Eye Disorders Treatments Product Type
Table 9. List of Global Tier 1 Eye Disorders Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eye Disorders Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eye Disorders Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Eye Disorders Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Eye Disorders Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Eye Disorders Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Eye Disorders Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Eye Disorders Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Eye Disorders Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Eye Disorders Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Eye Disorders Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Eye Disorders Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Eye Disorders Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Eye Disorders Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Eye Disorders Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Eye Disorders Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Eye Disorders Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Eye Disorders Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Eye Disorders Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Eye Disorders Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Eye Disorders Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Eye Disorders Treatments Product Offerings
Table 32. Johnson & Johnson Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Eye Disorders Treatments Product Offerings
Table 35. Novartis Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Alimera Sciences Corporate Summary
Table 37. Alimera Sciences Eye Disorders Treatments Product Offerings
Table 38. Alimera Sciences Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceutical Corporate Summary
Table 40. Teva Pharmaceutical Eye Disorders Treatments Product Offerings
Table 41. Teva Pharmaceutical Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 42. Eyetech Pharmaceuticals Corporate Summary
Table 43. Eyetech Pharmaceuticals Eye Disorders Treatments Product Offerings
Table 44. Eyetech Pharmaceuticals Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Refocus Group Corporate Summary
Table 46. Refocus Group Eye Disorders Treatments Product Offerings
Table 47. Refocus Group Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)
Table 48. VisionCare Ophthalmic Technologies Corporate Summary
Table 49. VisionCare Ophthalmic Technologies Eye Disorders Treatments Product Offerings
Table 50. VisionCare Ophthalmic Technologies Eye Disorders Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Eye Disorders Treatments Segment by Type in 2021
Figure 2. Eye Disorders Treatments Segment by Application in 2021
Figure 3. Global Eye Disorders Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eye Disorders Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eye Disorders Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eye Disorders Treatments Revenue in 2021
Figure 8. By Type - Global Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 12. US Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 24. China Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Eye Disorders Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Eye Disorders Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alimera Sciences Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceutical Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eyetech Pharmaceuticals Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Refocus Group Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. VisionCare Ophthalmic Technologies Eye Disorders Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)